Zelimkhan G. Berikkhanov

Dr. Zelimkhan G. Berikkhanov

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2025 in Scientific Reports
Verified
Journal Article
Open access
SASergey Avdeev
Sergey Avdeev
VGVilya Gaynitdinova
Vilya Gaynitdinova
ZMZamira M. Merzhoeva
Zamira M. Merzhoeva
GNGaliya S. Nuralieva
Galiya S. Nuralieva
ETEvgeniy A. Tarabrin
Evgeniy A. Tarabrin
QMQingyun Ma
Qingyun Ma
To assess N-Terminal Pro C-Type Natriuretic Peptide (NT-proCNP) plasma levels in patients with chronic obstructive pulmonary disease (COPD) and evaluate of its diagnostic value for pulmonary hypertension (PH) in COPD. According to the range of systolic pulmonary artery pressure (SPAP), the COPD patients were divided into group of patients without PH (SPAP < 40 mmHg, n = 42) and group of patients with PH (SPAP ≥40 mmHg, n = 52). Significant differences in NT-proCNP levels were found in patients with and without PH (3.63 ± 0.95 pg/mL vs. 1.42 ± 0.35 pg/mL, p < 0.001). Statistically significant correlations were shown between NT-proCNP levels and SPAP (r = 0.77, p < 0.001), mMRC dyspnea score (r = 0.42, p = 0.001), CAT score (r = 0.60, p < 0.001), and SpO2 (r = − 0.47, p = 0.001). Pulmonary hypertension in COPD patients was associated with higher plasma NT-proCNP levels.

12 December 2024 in Ekologiya cheloveka (Human Ecology)
Verified
Journal Article
Open access
PDF file
MVMikhail Yu. Valkov
Mikhail Yu. Valkov
AGAndrej M Grjibovski
Andrej M Grjibovski
AKAlexander V. Kudryavtsev
Alexander V. Kudryavtsev
MBMaxim A. Bogdanov
Maxim A. Bogdanov
DBDmitriy V. Bogdanov
Dmitriy V. Bogdanov
ГАГомболевский Виктор Александрович
Гомболевский Виктор Александрович
Aim: To present the ARILIS study aimed at assessing the use of artificial intelligence to analyze chest computed tomography (CT) data to predict and prevent non-cancer mortality in patients with cancer. Material and methods: This cohort study will include patients with cancer diagnosed in the Arkhangelsk region (AR) within the 2019–2023 period. The COVID-19 patients with pneumonia, patients with general medical conditions, and the population of the Know Your Heart Study are planned to be enrolled as control groups. To detect and quantify the CT signs of the cardiovascular, pulmonary, and bone disorders, the thoracic СT scans of all the subjects will be processed using the multi-targeted AI algorithm provided by the IRA Labs company. From the date of processing of the thoracic CT scans using the multi-targeted AI algorithm, the study subjects will be followed for new clinical diagnoses and all-cause mortality. Expected results: T he study will determine the prevalence of CT signs of the cardiovascular, pulmonary, and bone disorders in patients with cancer compared with the Know Your Heart Study population sample. It will also assess the incidence of cardiovascular, pulmonary, and bone events and all-cause mortality in patients with cancer compared with control groups, explore the potential of the IRA Labs’ multi-targeted AI algorithm in the assessment and reclassification of assessed risks in patients with cancer, and provide a software product for using mtIA in healthcare practice.

22 December 2025 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
VSVladislav Sergeevich Skossyrskiy
Vladislav Sergeevich Skossyrskiy
DSDaniil Stepochkin
Daniil Stepochkin
EZEkaterina Zaharova
Ekaterina Zaharova
RMRasim Mamedov
Rasim Mamedov
SMSergey Yurievich Muraviev
Sergey Yurievich Muraviev
VRVadim Rasumovsky
Vadim Rasumovsky

28 June 2024 in Health Care of the Russian Federation
Verified
Journal Article
Closed access
PDF file
SASergey Avdeev
Sergey Avdeev
ZBZelimkhan G. Berikkhanov
Zelimkhan G. Berikkhanov
ЗМЗамира Магомедовна Мержоева
Замира Магомедовна Мержоева
ИТИрина Павловна Титова
Ирина Павловна Титова
НСНикита Александрович Соколов
Никита Александрович Соколов
АААиша Шерматовна Ахмарова
Аиша Шерматовна Ахмарова
Introduction. There are no separate reports devoted to telemedicine consultations in pulmonology. Severe respiratory failure and distance of residence of many patients sometimes makes it impossible to transport them to specialized medical institutions. Telemedicine consultations in such cases make it much easier to receive medical care, conduct a Consilium or coordinate further treatment tactics at the patient’s place of residence. This article analyzes the results of telemedicine consultations of patients with pulmonary pathologies. Purpose. To evaluate the opportunities and main trends of providing medical care to pulmonary patients by means of telemedicine consultations. Materials and methods. We retrospectively analyzed the results of seven hundred one telemedicine consultation on pulmonary profile in the “doctor–doctor” format for the period of March–December, 2022 inclusive. The following parameters were analyzed: request type, request region, profile, diagnosis by ICD-10 classes, routing recommendations, and patient hospitalization. Results. The largest number of requests came from the Central (29.5%), Volga (22.5%) and Siberian (18%) Federal Districts. 302 cases were recommended for routing to federal centers, 57 patients were actually hospitalized. For interstitial lung diseases 266 (38%) telemedicine consultations were performed, pneumonias: 167 (24%), chronic obstructive pulmonary disease: 130 (19%), sarcoidosis: 33 (5%), which in total accounted for more than 85% of all telemedicine consultations performed. Research limitations: short analysis period (March–December 2022), low or no requests for telemedicine consultations from selected regions. Conclusion. The use of telemedicine consultations in pulmonology makes medical care more accessible to the population, which undoubtedly affects morbidity and mortality rates.

29 November 2025 in Cancers
Verified
Journal Article
Open access
PDF file
MSMaria Aleksandrovna Sukhanova
Maria Aleksandrovna Sukhanova
SMSergey Yurievich Muraviev
Sergey Yurievich Muraviev
ETEvgeniy A. Tarabrin
Evgeniy A. Tarabrin
ASAlexey L. Shestakov
Alexey L. Shestakov
ZBZelimkhan G. Berikkhanov
Zelimkhan G. Berikkhanov
AFAndrey P. Fabrika
Andrey P. Fabrika
Background: Metabolic instability, encompassing fluctuations in body weight, glucose, insulin, and sex hormones, may create a pro-inflammatory and proliferative endometrial microenvironment even in women with normal BMI. Methods: A systematic literature review was performed in PubMed, Embase, and Google Scholar, including studies assessing the relationship between metabolic, endocrine, and inflammatory factors and the risk of endometrial cancer in non-obese women. Results: Variability in body weight and hormonal parameters was associated with chronic subclinical inflammation, altered leptin/adiponectin secretion, decreased sex hormone-binding globulin, and increased estrogen bioavailability. These changes disrupt the homeostatic rhythm of endometrial cell regeneration and increase the likelihood of neoplastic transformation. Conclusions: Metabolic instability represents a novel integrated risk factor for endometrial cancer among women without obesity and should be incorporated into future risk stratification and prevention models.

7 June 2023 in Consilium Medicum
Verified
Journal Article
Open access
SASergey Avdeev
Sergey Avdeev
NVNikolay A. Voznesenskiy
Nikolay A. Voznesenskiy
ZMZamira M. Merzhoeva
Zamira M. Merzhoeva
LNLidia Yu. Nikitina
Lidia Yu. Nikitina
ZBZelimkhan G. Berikkhanov
Zelimkhan G. Berikkhanov
The article highlights the main activities of the National Medical Research Center for Pulmonology of the Sechenov University. The main results of clinical, analytical and educational activities are outlined. The prospects for the development of the pulmonological service of the Russian Federation, current problems and their solutions are determined.